AstraZeneca Signs Letter of Intent with IDT Biologika to Boost COVID-19 Vaccine Manufacturing Capability in the EU
Shots: AstraZeneca and IDT Biologika are exploring options to accelerate output of finished AZ’s COVID-19 vaccine in Q2’21 to support EU’s immediate vaccination needs during […]